Lowey Dannenberg, P.C. is Investigating The Ensign Group
Lowey Dannenberg P.C. is investigating The Ensign Group (NASDAQ: ENSG) for potential violations of federal securities laws. This investigation follows short-seller reports from Hunterbrook and Muddy Waters Research, alleging systemic quality-measure gaming, falsified care-quality data, improper related-party billing, and potential Medicare/Medicaid fraud. These reports caused significant drops in Ensign's stock price and led to substantial shareholder losses.
ENSG INVESTIGATION: Investigation Launched into The Ensign Group, Inc. and Attorneys Encourage Investors and Potential Witnesses to Contact Robbins Geller Rudman & Dowd LLP
Robbins Geller Rudman & Dowd LLP has launched an investigation into The Ensign Group, Inc. (NASDAQ: ENSG) following a report by Muddy Waters Research alleging that Ensign is deceiving the government. The report suggests potential multi-billion dollar liabilities and unsustainable margins due to ongoing misconduct. The law firm is encouraging investors who suffered losses and potential witnesses to come forward.
ENSG - Ensign Group Inc Latest SEC Filings
This article provides the latest SEC filings for Ensign Group Inc. (ENSG), along with detailed financial data, performance metrics, and analyst recommendations. It highlights key figures such as market capitalization, P/E ratio, dividend information, and institutional ownership, offering a comprehensive snapshot of the company's financial health and stock performance.
5 Best Medical Care Facilities Stocks to Buy According to Analysts
This article identifies five top medical care facilities stocks recommended by analysts, highlighting The Ensign Group, Inc. (ENSG) as one of them. Ensign Group recently expanded its portfolio by acquiring two skilled nursing facilities in Texas, bringing its total to 398 healthcare operations across 17 states. The company's business model offers investors exposure to both operating performance and healthcare real estate ownership.
Ensign Expands Texas Footprint With Two Skilled Nursing Acquisitions
The Ensign Group, Inc. (ENSG) has expanded its presence in Texas by acquiring the real estate and operations of two skilled nursing facilities: Las Ventanas de Socorro and Los Arcos del Norte Care Center. This move aligns with Ensign's strategy of growing through acquisitions in existing markets, utilizing its decentralized operating model to improve profitability and quality of care. The acquisition adds 250 licensed beds to its network, which now includes 398 healthcare operations across 17 states, and further strengthens its real estate portfolio.
ENSG - Ensign Group Inc Options
This page provides a detailed financial overview of Ensign Group Inc (ENSG) as of July 2, 2026. It includes key financial metrics, stock performance data, basic company information, and analyst recommendations. The data covers various aspects such as market capitalization, earnings, sales, dividends, insider and institutional ownership, and profitability ratios.
The Ensign Group focuses on long-term care growth. Operations and strategy remain in the foreground
The Ensign Group is expanding its skilled nursing and senior living footprint, focusing on disciplined operations and meeting long-term care demand. Its strategy empowers local operators and involves a pipeline of new and acquired facilities to serve an aging population. The company's revenue mixes government and private payers, emphasizing quality care and clinical documentation for reimbursement.
Ensign Group buys two nursing facilities in Texas
The Ensign Group has acquired the operations of two skilled nursing facilities in Texas: River Pointe and Riverbend. This move increases Ensign's presence in Texas, a state it has targeted for growth.
Ensign expands in Texas with two skilled nursing sites
The Ensign Group has expanded its presence in Texas by acquiring the real estate and operations of two skilled nursing facilities: Las Ventanas de Socorro (126 beds) and Los Arcos del Norte Care Center (124 beds), effective July 1, 2026. These acquisitions bring Ensign's total healthcare operations to 398 facilities across 17 states, with 183 owned real estate assets. The company continues to seek opportunities to acquire additional skilled nursing, senior living, and healthcare-related businesses nationwide.
The Ensign Group Purchases Real Estate and Operations in Texas
The Ensign Group, Inc. has acquired the real estate and operations of two skilled nursing facilities in Texas: "Las Ventanas de Socorro" and "Los Arcos del Norte Care Center." These acquisitions, effective July 1, 2026, expand Ensign's presence in the state and bring its total portfolio to 398 healthcare operations across 17 states, with 183 real estate assets owned by its subsidiaries. The company continues to seek opportunities for further expansion in the healthcare sector.
Ensign Group acquires two Texas skilled nursing facilities
The Ensign Group, Inc. has expanded its portfolio by acquiring two skilled nursing facilities in Texas: Las Ventanas de Socorro and Los Arcos del Norte Care Center. These acquisitions, which include both real estate and operations, bring Ensign's total healthcare operations to 398 across 17 states, demonstrating the company's continued growth with revenue climbing 19% over the last twelve months. The company has also raised its dividend for 19 consecutive years, though it faces increased scrutiny and a stock price drop due to recent short reports alleging inadequate patient care and compliance issues.
The Ensign Group Announces Acquisition of Two Texas Skilled Nursing Facilities in Socorro and El Paso
The Ensign Group, Inc. has acquired two skilled nursing facilities in Texas: "Las Ventanas de Socorro" and "Los Arcos del Norte Care Center," expanding its portfolio to 398 healthcare operations across 17 states. These acquisitions, effective July 1, 2026, bolster Ensign's presence in Texas, with its real estate subsidiary, Standard Bearer Healthcare REIT, acquiring the properties. The company's CEO, Barry Port, emphasized that Ensign is actively pursuing additional acquisition opportunities in the skilled nursing and senior living sectors.
How Investors Are Reacting To Ensign Group (ENSG) Shifting Into Russell 1000 And Value Benchmarks
The Ensign Group (ENSG) was reclassified into the Russell 1000, Midcap, and various value/defensive benchmarks in late June 2026, exiting growth and small-cap indices. This shift, driven by Ensign's acquisition-based expansion in post-acute and senior care, could impact institutional investor exposure and short-term stock flows as different funds adjust their positions. Investors need to consider the company's valuation, potential pricing pressures, and execution risks as its portfolio grows, despite ongoing acquisitions and raised guidance.
How Investors Are Reacting To Ensign Group (ENSG) Shifting Into Russell 1000 And Value Benchmarks
The Ensign Group, Inc. (ENSG) recently shifted into the Russell 1000, Russell Midcap, and various value and defensive benchmarks, while exiting growth and small-cap indices. This reclassification affects the types of institutional investors likely to hold ENSG stock. The article discusses Ensign Group's investment narrative, including its valuation and acquisition-driven strategy, and highlights the ongoing debate among investors regarding its fair value and potential risks despite positive catalysts.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation – ENSG
The Rosen Law Firm is investigating potential securities class action claims against The Ensign Group, Inc. (NASDAQ: ENSG) following allegations that the company's stock fell after a short seller report. The report claimed Ensign's business model relies on inadequate patient care and gaming quality metrics, leading to patient suffering and deaths, while routing taxpayer dollars to executives. Investors who purchased Ensign securities are encouraged to contact the Rosen Law Firm to inquire about joining the prospective class action.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Ensign Group, Inc. - ENSG
Pomerantz LLP is investigating claims against The Ensign Group, Inc. following two short reports that caused significant stock price drops. Hunterbrook alleged inadequate patient care and questionable financial practices, while Muddy Waters Research claimed potential Medicare and Medicaid fraud related to the renting of administrator licenses. Investors of Ensign Group (NASDAQ: ENSG) are encouraged to contact Pomerantz LLP regarding these allegations.
The Ensign Group (ENSG) Shares Fall Amid Activist Forensic Reports Challenging Patient Care Claims, Legal Compliance -- HBSS
Shares of The Ensign Group (ENSG) fell over 11% following critical reports from Hunterbrook Media and Muddy Waters Research, which questioned Ensign's patient care, legal compliance, and business practices. The reports allege that Ensign's profits stem from providing less care than required and that the company may be using "rented" NHA licenses, potentially constituting fraud against federal and state programs. Shareholder rights firm Hagens Berman has launched an investigation into whether Ensign misled investors and violated federal securities laws.
ENSG Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages The Ensign Group, Inc. (NASDAQ: ENSG) Investors to Contact the Firm
Kessler Topaz Meltzer & Check, LLP (KTMC) is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potential federal securities law violations following a report by Hunterbrook Media titled “Ensign: The Nursing Home Empire Built On Fatal Neglect.” The report alleges chronic understaffing, inadequate patient care, misleading quality metrics, and improper billing practices leading to an over 8% drop in ENSG's stock price. KTMC is encouraging investors who experienced losses to contact the firm to discuss their legal rights.
ENSG Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages The Ensign Group, Inc. (NASDAQ: ENSG) Investors to Contact the Firm
Kessler Topaz Meltzer & Check, LLP is investigating potential securities law violations by The Ensign Group, Inc. (NASDAQ: ENSG) after a report alleged the company's growth was driven by chronic understaffing and inadequate patient care, causing its stock to drop over 8%. The law firm is encouraging investors who experienced losses to contact them to discuss their legal rights. The report, titled “Ensign: The Nursing Home Empire Built On Fatal Neglect,” claimed issues like misleading quality metrics, improper billing, and manipulated performance data.
The Ensign Group (NASDAQ: ENSG) is being investigated by
Lowey Dannenberg P.C. is investigating The Ensign Group (NASDAQ: ENSG) for potential violations of federal securities laws. This investigation follows two short-seller reports from Hunterbrook and Muddy Waters Research, alleging systemic quality-measure gaming, falsified care-quality data, improper related-party billing, and potential Medicare/Medicaid fraud. These allegations have led to significant drops in Ensign's stock price and substantial shareholder losses.
$ENSG Notification: Ensign Investigated for Misrepresentations about its Regulatory Issues after 8% Stock Drop
Bleichmar Fonti & Auld LLP (BFA) has announced an investigation into The Ensign Group, Inc. (NASDAQ: ENSG) for potential securities fraud. This comes after significant stock drops following reports alleging the company misrepresented the quality of care at its nursing facilities and its regulatory compliance. Two research reports, one from Hunterbrook Capital and another from Muddy Waters Research, detailed how Ensign allegedly boosted profits by understaffing facilities and engaging in deceptive regulatory practices, leading to an 8.2% and 3% stock decline respectively.
Price to book forward of The Ensign Group, Inc. – NASDAQ:ENSG
This article provides financial information for The Ensign Group, Inc. (NASDAQ: ENSG), focusing on its price-to-book forward metric. It details the company's market data, financial overview, news, and community sections available on the TradingView platform. The content is primarily a listing of navigation and informational categories related to ENSG on TradingView.
The Ensign Group, Inc.(NasdaqGS: ENSG) dropped from Russell 2500 Growth Benchmark
The Ensign Group, Inc. (NasdaqGS: ENSG) has been removed from the Russell 2500 Growth Benchmark. This news comes amidst several recent changes to its index inclusions, including being dropped from Russell Small Cap Comp Growth and Russell 2000 Growth benchmarks, while being added to Russell Midcap Value and Russell 1000 Value benchmarks. The company's stock experienced a 2.98% drop on the day of the announcement.
Enterprise value to EBITDA forward of Ensign Group, Inc. – SWB:EGB
This page provides financial data for Ensign Group, Inc. (SWB:EGB) focusing on its enterprise value to EBITDA forward metric. The information is sourced from TradingView, utilizing market data from ICE Data Services and reference data from FactSet. The article itself is very brief and acts more as a data point title within a larger financial platform.
ENSG INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into The Ensign Group, Inc. and Encourages Investors and Potential Witnesses to Contact Law Firm
Robbins Geller Rudman & Dowd LLP has initiated an investigation into The Ensign Group, Inc. (NASDAQ: ENSG) following a report by Muddy Waters Research alleging fraud and potential liabilities. The firm is encouraging investors who have suffered losses and potential witnesses to come forward. The investigation centers on alleged violations of U.S. federal securities laws.
The Ensign Group, Inc.(NasdaqGS: ENSG) dropped from Russell 2000 Growth Benchmark
The Ensign Group, Inc. (NasdaqGS:ENSG) has been removed from the Russell 2000 Growth Benchmark index. This change comes shortly after the company was added to the Russell 1000 Value Benchmark, indicating a reclassification of its market identity by Russell indices. The company's stock has seen recent activity including an increased stock repurchase program and new acquisitions of healthcare facilities.
The Ensign Group, Inc.(NasdaqGS: ENSG) added to Russell 1000 Value Benchmark
The Ensign Group, Inc. (NasdaqGS:ENSG) has been added to the Russell 1000 Value Benchmark. This news comes shortly after the company was dropped from the Russell 2000 Growth Benchmark and the Russell 3000E Growth Benchmark. The Ensign Group provides skilled nursing and senior living services across multiple states, operating approximately 396 healthcare facilities.
Price to sales forward of The Ensign Group, Inc. – NASDAQ:ENSG
This article provides financial data for The Ensign Group, Inc. (NASDAQ: ENSG), specifically focusing on its forward price-to-sales ratio. It presents various financial metrics and allows users to access more detailed financial information, news, and community discussions. The content is primarily a data point from TradingView's platform.
Ensign Group, Inc. Actuals & Estimates (NASDAQ:ENSG)
This article provides an overview of The Ensign Group, Inc. (NASDAQ:ENSG) stock, including its current price, historical performance, analyst forecasts, and financial data. It covers frequently asked questions about the company's stock price volatility, market capitalization, earnings reports, revenue, net income, dividends, employee count, and EBITDA. The report also offers guidance on how to buy ENSG stocks and investment recommendations based on technical analysis.
The Ensign Group (NASDAQ: ENSG) is being investigated over potential violations of Federal Securities Laws
Lowey Dannenberg P.C. is investigating The Ensign Group (NASDAQ: ENSG) for potential violations of federal securities laws. This investigation follows two short-seller reports alleging issues including systemic quality-measure gaming, falsified care-quality data, improper related-party billing, and possible Medicare and Medicaid fraud, which caused significant drops in Ensign's stock price and shareholder losses. The law firm is assessing whether the company provided accurate and complete information to investors.
ENSG Forecast — Price Target — Prediction for 2027
The Ensign Group, Inc. (ENSG) currently trades at $163.05, with analysts providing a 1-year price target ranging from $210.00 to $230.00. The stock has shown a 6.23% increase over the last year, despite recent monthly and daily decreases. The company is set to release its next earnings report on July 23, 2026.
ROSEN, LEADING TRIAL LAWYERS, Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG
The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) following a short seller report alleging inadequate patient care and "gaming quality metrics." Investors who purchased Ensign securities are encouraged to inquire about a prospective class action to recover losses. The firm highlights its experience and success in securities class actions.
Price to earnings forward of The Ensign Group, Inc. – NASDAQ:ENSG
This article provides the forward price-to-earnings ratio for The Ensign Group, Inc. (NASDAQ: ENSG). It offers financial data and market information for the company, accessible through TradingView's platform. The content is presented within the context of market data and financial tools provided by various financial data entities.
Enterprise value to revenue forward of The Ensign Group, Inc. – NASDAQ:ENSG
The article focuses on the enterprise value to revenue forward of The Ensign Group, Inc. (NASDAQ: ENSG). It appears to be a financial data page from TradingView, displaying various financial metrics and relevant information for the company. The content itself is minimalist, primarily serving as a header for a data table or chart not included in the provided text.
Ensign Group, Inc. Actuals & Estimates (BOATS:ENSG)
This article provides an overview of The Ensign Group, Inc. (ENSG) stock, focusing on its actual financial results versus analyst estimates. It details income statement, balance sheet, and cash flow data, along with valuation metrics and stock performance. Key information includes forecast prices, historical highs and lows, upcoming earnings dates, recent earnings and revenue figures, net income, dividend information, and employee count.
ENSG Investigation: Kessler Topaz Meltzer & Check, LLP Encourages The Ensign Group, Inc. (NASDAQ: ENSG) Investors to Contact the Firm
Kessler Topaz Meltzer & Check, LLP is investigating The Ensign Group, Inc. (NASDAQ: ENSG) after a report alleged that the company's growth was fueled by chronic understaffing and inadequate patient care, leading to an over 8% drop in stock price. The law firm is encouraging investors who experienced financial losses to contact them to discuss their legal rights. The investigation focuses on potential violations of federal securities laws.
Price to book forward of Ensign Group, Inc. – MIL:1ENSG
This article focuses on the "Price to book forward" financial metric for Ensign Group, Inc. (MIL:1ENSG), a company listed on Euronext Milan. The content is primarily a data placeholder, indicating various financial overviews and market information available on the TradingView platform for this stock. It highlights that the market was closed at the time of publication and no trades were recorded.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Ensign Group, Inc. - ENSG
Pomerantz LLP is investigating The Ensign Group, Inc. (NASDAQ: ENSG) following a short report by Hunterbrook alleging inadequate patient care, understaffing, and misappropriation of taxpayer funds. The report, published on June 8, 2026, claims Ensign Group's profits rely on these practices, leading to negative patient outcomes. Following the report, Ensign Group's stock price dropped by 8.15%.
RGRD Launches Investigation into The Ensign Group, Inc.
Robbins Geller Rudman & Dowd LLP has initiated an investigation into The Ensign Group, Inc. (NASDAQ: ENSG) following a report by Muddy Waters Research claiming the company engaged in deceiving the government, leading to a significant drop in Ensign's stock price. The law firm is encouraging investors who suffered losses and individuals with relevant information to contact them regarding potential violations of U.S. federal securities laws.
ENSG Investigation: Kessler Topaz Meltzer & Check, LLP Encourages The Ensign Group, Inc. (NASDAQ: ENSG) Investors to Contact the Firm
Kessler Topaz Meltzer & Check, LLP (KTMC) is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potential federal securities law violations. This follows a report from Hunterbrook Media alleging that Ensign's growth was fueled by chronic understaffing and inadequate patient care, leading to an over 8% drop in the company's stock price. KTMC is encouraging investors who experienced financial losses to contact the firm to discuss their legal rights.
THE ENSIGN GROUP, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates The Ensign Group, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ENSG
Scott+Scott Attorneys at Law LLP has initiated an investigation into whether the directors and officers of The Ensign Group, Inc. (NASDAQ: ENSG) breached their fiduciary duties, potentially causing damages to the company and its shareholders. This investigation follows a short report by Muddy Waters Research on June 11, 2026, alleging potential Medicare and Medicaid fraud involving the rental of administrator licenses for skilled nursing facilities. Shareholders are invited to join the investigation, led by attorney Joseph A. Pettigrew.
NASDAQ: ENSG Investigation: Kessler Topaz Meltzer & Check,
Kessler Topaz Meltzer & Check, LLP is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potential securities law violations following a report by Hunterbrook Media. The report, "Ensign: The Nursing Home Empire Built On Fatal Neglect," alleges chronic understaffing, inadequate patient care, and misleading quality metrics, which led to an over 8% drop in ENSG's stock price. Investors who experienced losses are encouraged to contact KTMC for a legal consultation.
Bronstein, Gewirtz & Grossman, LLC Encourages The Ensign Group, Inc. (ENSG) Shareholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Ensign Group, Inc. (NASDAQ:ENSG) following a short-seller report. The report by Hunterbrook alleged that Ensign's business model relies on inadequate patient care, understaffing facilities, and gaming quality metrics, leading to a sharp drop in ENSG's stock price on June 8, 2026. The firm encourages affected investors to contact them for more information and to assist in the investigation.
Lowey Dannenberg, P.C. is Investigating The Ensign Group (NASDAQ: ENSG) for Potential Violations of the Federal Securities Laws
Lowey Dannenberg P.C. is investigating The Ensign Group (NASDAQ: ENSG) for potential federal securities law violations. This investigation follows short-seller reports from Hunterbrook and Muddy Waters Research, alleging quality-measure gaming, falsified care data, improper related-party billing, and possible Medicare and Medicaid fraud. These reports have led to significant drops in ENSG's stock price and substantial shareholder losses.
NASDAQ: ENSG Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages The Ensign Group, Inc. (NASDAQ: ENSG) Investors to Contact the Firm
Kessler Topaz Meltzer & Check, LLP is investigating potential federal securities law violations by The Ensign Group, Inc. (NASDAQ: ENSG). This investigation follows a report alleging that ENSG's growth was fueled by chronic understaffing and inadequate patient care in its nursing facilities, leading to an over 8% drop in its stock price. The firm encourages investors who experienced losses to contact them to discuss their legal rights.
Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG
The Rosen Law Firm has initiated an investigation into potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) following allegations of misleading business information. This probe comes after a short seller report claimed Ensign's profits rely on inadequate patient care and "gaming quality metrics," leading to patient suffering and deaths. Investors who purchased Ensign securities are encouraged to contact the Rosen Law Firm to inquire about joining a prospective class action to recover losses.
Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG
The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) following allegations of misleading business information. This investigation comes after a short seller report claimed Ensign's business model relies on inadequate patient care and "gaming quality metrics," leading to an 8.15% stock drop on June 8, 2026. Investors who purchased Ensign securities are encouraged to contact the firm regarding a potential class action lawsuit to recover losses.
Number of shareholders of Ensign Group, Inc. – BX:ENSG
The article focuses on reporting the number of shareholders for Ensign Group, Inc. (BX:ENSG). It presents a data point for shareholders ("Value") and tracks its change over a period. The page structure also indicates this information is part of a broader financial data overview on TradingView.
The Ensign Group, Inc. Announces Increased Stock Repurchase Authorization
The Ensign Group, Inc. announced that its Board of Directors has increased the company's stock repurchase authorization by an additional $100 million, bringing the total authorized repurchase program to $300 million. The company has already repurchased $162.7 million in stock through June 2026, demonstrating continued confidence in its financial strength and future prospects. This move reflects Ensign's commitment to returning value to shareholders and maintaining a strong capital structure.
How Investors May Respond To Ensign Group (ENSG) Care Allegations, Probes, Buybacks, And Dividends
The Ensign Group has recently faced allegations of inadequate patient care and regulatory non-compliance, alongside ongoing share buybacks and declared dividends. These issues raise questions about management's priorities and the company's risk profile, potentially reshaping its investment narrative. Despite these concerns, the company is also engaging in capital return measures, indicating management's confidence in the stock.
